CausalSentinel

Protein Dossier — KLK12 (Kallikrein-12)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Neo-extraversion 0.286 0.119 0.0164 Wald ratio 1 cis NA
Myocardial infarction 0.043 0.0184 0.0193 Wald ratio 1 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine -0.0677 0.0291 0.0202 Wald ratio 1 cis NA
Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip] -0.0767 0.0348 0.0276 Wald ratio 1 cis NA
Non-cancer illness code self-reported: muscle or soft tissue injuries -0.109 0.0511 0.0334 Wald ratio 1 cis NA
Microalbuminuria -0.0772 0.0365 0.0348 Wald ratio 1 cis NA
Diagnoses - main ICD10: M54 Dorsalgia 0.0568 0.0284 0.0455 Wald ratio 1 cis NA
Iron 0.0314 0.0158 0.0474 Wald ratio 1 cis NA
Hearing difficulty or problems: Yes -0.0133 0.00677 0.0495 Wald ratio 1 cis NA
Sleep duration -0.00589 0.00302 0.051 Wald ratio 1 cis NA
Diagnoses - main ICD10: N81 Female genital prolapse 0.0589 0.0305 0.0533 Wald ratio 1 cis NA
Packed cell volume 0.0532 0.0276 0.054 Wald ratio 1 cis NA
…and 96 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3199_54_2 kallikrein 12 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

50 association rows across 20 traits (48 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating KLK12 levels 2e-7562 rs3745540 7 GCST90860580 no MR -> candidate analysis
Circulating KLK13 levels 3e-1112 rs3760739 2 GCST90860002 no MR -> candidate analysis
Kallikrein-12 levels 6e-212 rs3745540 7 GCST90161667 no MR -> candidate analysis
Kallikrein-13 levels 3e-189 rs2569459 3 GCST90248158 no MR -> candidate analysis
KLK12 protein levels 2e-182 rs77342236 9 GCST90469698 no MR -> candidate analysis
KLK10 protein levels 6e-102 rs35996455 3 GCST90469696 no MR -> candidate analysis
Circulating KLK10 levels 8e-101 rs3760744 1 GCST90860356 no MR -> candidate analysis
KLK14 protein levels 2e-96 rs2569459 2 GCST90469700 no MR -> candidate analysis
Serum levels of protein KLK13 1e-79 rs2569459 2 GCST90086572 no MR -> candidate analysis
Blood protein levels 4e-54 rs3760739 2 GCST006585 no MR -> candidate analysis
Circulating KLK14 levels 1e-44 rs8103083 1 GCST90860034 no MR -> candidate analysis
Kallikrein-12 levels (KLK12.3199.54.2) 3e-34 rs3745540 1 GCST90241671 no MR -> candidate analysis
…and 8 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

No genetically-associated diseases retrieved from Open Targets.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Kallikrein-12)
gnomAD constraint pLI=1.9e-09, LOEUF=1.63 — LoF-tolerant
GWAS Catalog 190 unique SNPs / 466 rows
ClinVar 76 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance